Effect of Propranolol on Motor Cortex Excitability in Essential Tremor: An Exploratory Study

Area of Science:

• Neuroscience
• Movement Disorders
• Pharmacology

Background:

• Essential tremor is the most common movement disorder, yet its pathophysiology is poorly understood.
• Propranolol, a beta-blocker, is a first-line treatment for essential tremor, with effects often attributed to peripheral actions.
• Central nervous system effects of propranolol in essential tremor remain largely unexplored.

Purpose of the Study:

• To investigate the impact of propranolol on primary motor cortex (M1) excitability in essential tremor patients.
• To compare central adrenergic effects of propranolol in essential tremor patients versus healthy controls.

Main Methods:

• Utilized transcranial magnetic stimulation (TMS) to assess M1 excitability.
• Measured parameters including motor thresholds, motor evoked potentials, cortical silent period, and input/output curves.
• Administered placebo and propranolol to essential tremor patients and a control group.

Main Results:

• Essential tremor patients exhibited left M1 cortical inhibition and right M1 cortical excitation four hours post-propranolol administration.
• No significant changes in cortical excitability were observed after placebo administration.
• Hemispheric differences in M1 excitability modulation by propranolol were evident.

Conclusions:

• Findings suggest differential noradrenergic modulation of excitation and inhibition in the motor cortex.
• Further research is needed to explore these central effects in diverse essential tremor populations and left-handed individuals.
• This study highlights the complex central nervous system actions of propranolol in essential tremor.